A Phase II Study of Perifosine in Patients With Relapsed/Refractory Waldenström's Macroglobulinemia

NCT00398710 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Waldenström's Macroglobulinemia

Interventions

DRUG: Perifosine

Sponsor

AEterna Zentaris

Collaborators

[object Object]